TELA Bio, Inc. (TELA)
US — Healthcare Sector
Automate Your Wheel Strategy on TELA
With Tiblio's Option Bot, you can configure your own wheel strategy including TELA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TELA
- Rev/Share 1.5733
- Book/Share 0.4004
- PB 3.397
- Debt/Equity 2.3068
- CurrentRatio 4.2178
- ROIC -0.6478
- MktCap 53794800.0
- FreeCF/Share -0.8318
- PFCF -1.4287
- PE -1.4171
- Debt/Assets 0.5412
- DivYield 0
- ROE -4.0245
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | TELA | Piper Sandler | Overweight | Neutral | $5 | $2 | March 21, 2025 |
News
About TELA Bio, Inc. (TELA)
- IPO Date 2019-11-08
- Website https://www.telabio.com
- Industry Medical - Devices
- CEO Mr. Antony Koblish
- Employees 209
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.